In this instalment to our human interest series, we speak to the new business development executive to the North American clinical sales team of PCI Clinical Services, Jamie Weishaar.
Partner to the healthcare and pharma industry, Gerresheimer has announced it will complete its product portfolio of prefillable syringes through an exclusive licence from West Pharmaceutical Services.
Lonza has announced that, following receipt of all required regulatory approvals, it has completed its acquisition of Capsugel for $5.5 billion in cash, including refinancing of existing Capsugel debt of $2 billion.
Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets.
In our inaugural Q&A of our new ‘Meet the maker’ series, EPM gets to know Ashley Parish, who has recently been appointed vice president, strategic alliances of teckro — a global life sciences mobile technology company
As Catalent further expands its softgel drug delivery capabilities with its acquisition of Accucaps, we speak with June Lin, global marketing director consumer health softgel, about the benefits these expanded capabilities will offer.
Despite a downturn in M&A activity during the latter part of 2016, prospects are on the rise. In this article, we analyse what deals are on the table, coming to the table and those that are still in the kitchen waiting to be plated up!
Chris Wilkinson, head of sales for Healthcare and Public Sector for Siemens Financial Services, UK, writes about the importance for pharma to keep up with technological advancements and how flexible financing can help.
Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic alternative, Staphefekt
Johnson Matthey recently expanded its Cambridge facility to add process development and small-scale manufacturing capabilities. Brian Fairley and Antonio Zanotti-Gerosa explain how this will benefit pharmaceutical manufacturing
